In SLE lupus prone mice, targeted delivery of a CaMK4 inhibitor to podocytes preserved their ultrastructure, prevented immune complex deposition and crescent formation, and suppressed proteinuria. Here, CAMK4 is linked to systemic lupus erythematosus.